Sign in
4

Changes in Ownership

RESMED INC Filed Acc 0001127602-22-026096

Options or other derivatives

  • Chief Executive Officer acquired 36,569 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Farrell Michael J. · Chief Executive Officer

Table II: Derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2022-11-16 Grant or award : show line 1 in the form ResMed Common Stock Options +36,569 $224.58 $8,212,666 36,569 D
Loading xslF345X03/form4.xml…